QDEL

RBC Capital Reiterates QuidelOrtho (QDEL) Outperform Recommendation

Fintel reports that on September 19, 2023, RBC Capital reiterated coverage of QuidelOrtho (NASDAQ:QDEL) with a Outperform recommendation.

Analyst Price Forecast Suggests 60.59% Upside

As of August 31, 2023, the average one-year price target for QuidelOrtho is 120.51. The forecasts range from a low of 81.81 to a high of $176.40. The average price target represents an increase of 60.59% from its latest reported closing price of 75.04.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for QuidelOrtho is 2,857MM, a decrease of 9.63%. The projected annual non-GAAP EPS is 5.36.

What is the Fund Sentiment?

There are 4 funds or institutions reporting positions in QuidelOrtho. This is a decrease of 1 owner(s) or 20.00% in the last quarter. Average portfolio weight of all funds dedicated to QDEL is 1.05%, an increase of 17.87%. Total shares owned by institutions decreased in the last three months by 15.43% to 468K shares. QDEL / QuidelOrtho Corporation Put/Call Ratios The put/call ratio of QDEL is 0.50, indicating a bullish outlook.

What are Other Shareholders Doing?

QDEL / QuidelOrtho Corporation Shares Held by Institutions

Norges Bank holds 401K shares representing 0.60% ownership of the company. In it's prior filing, the firm reported owning 422K shares, representing a decrease of 5.00%. The firm decreased its portfolio allocation in QDEL by 15.89% over the last quarter.

Birchview Capital holds 65K shares representing 0.10% ownership of the company. In it's prior filing, the firm reported owning 61K shares, representing an increase of 5.98%. The firm decreased its portfolio allocation in QDEL by 5.30% over the last quarter.

Mendota Financial Group holds 1K shares representing 0.00% ownership of the company. No change in the last quarter.

Huntington National Bank holds 0K shares representing 0.00% ownership of the company. No change in the last quarter.

QuidelOrtho Background Information
(This description is provided by the company.)

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.